Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPX in Alanine/Alanine SOD2 Genotype Prostate Cancer
NCT03535675Phase 3Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 2018
- Primary completion
- Jul 2022
- Modality
- Dietary Supplement, PE (Plant Extract)
- Countries
- 1
01
Overview
A Phase 3 trial of Muscadine Grape Skin Extract in prostate adenocarcinoma, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Oct 2018; status: terminated.
02
Drugs
Muscadine Grape Skin Extract
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT03535675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03535675.